Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$1.5 million.

  • Firefly Neuroscience's Cash from Operations rose 4092.89% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year decrease of 3965.49%. This contributed to the annual value of -$6.2 million for FY2024, which is 18337.94% down from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Cash from Operations is -$1.5 million, which was up 4092.89% from -$2.4 million recorded in Q2 2025.
  • Firefly Neuroscience's Cash from Operations' 5-year high stood at $491536.0 during Q3 2023, with a 5-year trough of -$2.6 million in Q4 2022.
  • Over the past 5 years, Firefly Neuroscience's median Cash from Operations value was -$1.2 million (recorded in 2024), while the average stood at -$1.2 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 129568.67% in 2022, then soared by 16608.84% in 2023.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Cash from Operations stood at -$309205.0 in 2021, then tumbled by 735.83% to -$2.6 million in 2022, then skyrocketed by 80.27% to -$510000.0 in 2023, then plummeted by 138.82% to -$1.2 million in 2024, then decreased by 22.17% to -$1.5 million in 2025.
  • Its Cash from Operations stands at -$1.5 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$2.5 million for Q1 2025.